| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 63 |
| 1 | PANTOPRAZOLE | 51 |
| 2 | DEXAMETHASONE | 47 |
| 3 | DEXAMETHASONE 1.5 MG | 47 |
| 4 | ASPIRIN | 44 |
| 5 | ASPIRIN 325 MG | 43 |
| 6 | ASPIRIN 81 MG | 43 |
| 7 | PREDNISONE | 41 |
| 8 | OMEPRAZOLE MAGNESIUM | 36 |
| 9 | AMLODIPINE | 34 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TOLMETIN SODIUM | 1 | 0.0059 |
| 1 | USTEKINUMAB-AUUB | 1 | 0.0057 |
| 2 | PIVMECILLINAM | 1 | 0.0053 |
| 3 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 4 | ACAMPROSATE CALCIUM | 1 | 0.0030 |
| 5 | FOSCARNET SODIUM | 12 | 0.0030 |
| 6 | BEVACIZUMAB-BVZR | 2 | 0.0028 |
| 7 | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN, PHENYLEPHRINE HCL | 1 | 0.0028 |
| 8 | DACOMITINIB | 2 | 0.0027 |
| 9 | CLINDAMYCIN PHOSPHATE | 14 | 0.0025 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 119 |
| 1 | Kinase Inhibitor [EPC] | 94 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 83 |
| 3 | Factor Xa Inhibitor [EPC] | 67 |
| 4 | Proton Pump Inhibitor [EPC] | 53 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 47 |
| 6 | beta-Adrenergic Blocker [EPC] | 41 |
| 7 | HMG-CoA Reductase Inhibitor [EPC] | 39 |
| 8 | Dihydropyridine Calcium Channel Blocker [EPC] | 37 |
| 9 | Benzodiazepine [EPC] | 34 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 3 | 0.0044 |
| 1 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 3 | 0.0024 |
| 2 | CD38-directed Cytolytic Antibody [EPC] | 10 | 0.0017 |
| 3 | Humanized Monoclonal Antibody Fragment [EPC] | 2 | 0.0014 |
| 4 | Sulfonamide Antibacterial [EPC] | 5 | 0.0013 |
| 5 | Lipid-based Polyene Antifungal [EPC] | 14 | 0.0011 |
| 6 | Guanylate Cyclase-C Agonist [EPC] | 2 | 0.0010 |
| 7 | Provitamin D2 Compound [EPC] | 22 | 0.0007 |
| 8 | Nucleoside Analog Antifungal [EPC] | 1 | 0.0007 |
| 9 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 14 | 0.0006 |